Review summary
Teaching objective: Prolonged grief disorder in a 69-year-old writer and humorist a year after his wife's death, after the earlier deaths of a son and a daughter. The episode covers the DSM-5-TR criteria and the PG-13-R; telling prolonged grief from normal grief and from major depression with the PHQ-9 and a clinical interview, and the decision not to start an antidepressant when major depression is absent; a structured safety assessment for passive thoughts of death in an older bereaved man, who is at high risk of suicide, with means safety and the 988 Suicide & Crisis Lifeline; prolonged grief disorder therapy (Shear) in sixteen weekly sessions; sleep without sedative-hypnotics; tobacco use disorder in a cigar smoker since boyhood, with counseling and varenicline under the USPSTF recommendation; exertional chest tightness evaluated with an ECG and CT coronary angiography under the 2021 chest pain guideline, and nonobstructive coronary disease treated with a high-intensity statin and aspirin; gout with allopurinol started low and raised to a urate below 6 mg/dL, with colchicine prophylaxis and a flare treated without stopping allopurinol, under the ACR 2020 guideline; and social connection and his writing as part of recovery.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| November 30, 1835 | Born Samuel Langhorne Clemens in Florida, Missouri. | CLM-0001 |
| February 2, 1870 | Marries Olivia Langdon. | CLM-0003 |
| June 1872 | Death of his son Langdon from diphtheria. | CLM-0004 |
| 1894 | His publishing company fails; first attack of gout, in Paris, about this time. | CLM-0005, CLM-0010 |
| July 14, 1895 | Leaves on a worldwide lecture tour to repay his debts. | CLM-0005 |
| August 1896 | Death of his daughter Susy from meningitis. | CLM-0006 |
| October 1897 | Laid up with gout in Vienna. | CLM-0010 |
| June 5, 1904 | Death of his wife near Florence. | CLM-0007 |
| May 18, 1905 | Arrives for the summer at Dublin, New Hampshire. | CLM-0011 |
| August 1905 | A severe attack of gout in Norfolk, Connecticut. | CLM-0012 |
| April to May 1906 | Bronchitis in New York. | CLM-0013 |
| June to July 1909 | First attacks of chest pain; told he has a "tobacco heart." | CLM-0014, CLM-0009 |
| December 24, 1909 | Death of his daughter Jean. | CLM-0015 |
| April 21, 1910 | Dies at Stormfield of angina pectoris; his obituary says his losses had preyed upon his mind. | CLM-0016, CLM-0008 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Samuel Langhorne Clemens was born on November 30, 1835, in Florida, Missouri, the sixth of seven children; at four he moved with his family to Hannibal, Missouri, on the Mississippi River. Anchors the synthetic date of birth (November 30 kept). |
confirmed | Mark Twain: A Life Lived in a Rapidly Changing World (biography) supports Mark Twain Is Dead at 74. The New York Times, April 22, 1910 (transcription) supports HISTMED Master Roster v3 context |
| D | Writing for a Virginia City, Nevada, newspaper, he first used the pen name Mark Twain; he became a celebrated writer, humorist and lecturer, author of The Adventures of Tom Sawyer and Adventures of Huckleberry Finn. Anchors his work as a writer and lecturer in the modern social history. |
confirmed | Mark Twain: A Life Lived in a Rapidly Changing World (biography) supports Mark Twain Is Dead at 74. The New York Times, April 22, 1910 (transcription) supports |
| D | He married Olivia (Livy) Langdon in 1870; they had a son and three daughters. Family history as context; no relative is given a role in the modern episode. |
confirmed | Mark Twain: A Life Lived in a Rapidly Changing World (biography) supports Twain in Elmira: timeline supports |
| D | Their first child, Langdon, died of diphtheria in 1872, at about two years old. The first of the documented bereavements. |
confirmed | Mark Twain: A Life Lived in a Rapidly Changing World (biography) supports Twain in Elmira: timeline supports |
| D | Bad investments brought him to bankruptcy: his publishing company failed in 1894, and from July 1895 to July 1896 he made a worldwide lecture tour to earn money; he repaid his creditors. Anchors the documented financial ruin and recovery in the modern social history. |
confirmed | Mark Twain: A Life Lived in a Rapidly Changing World (biography) supports Twain in Elmira: timeline supports Mark Twain Is Dead at 74. The New York Times, April 22, 1910 (transcription) supports |
| D | His eldest daughter, Susy, died of meningitis in August 1896, at 24, while staying at the family's former home in Hartford; the family never returned to live in Hartford. The second documented bereavement. |
confirmed | Mark Twain: A Life Lived in a Rapidly Changing World (biography) supports Twain in Elmira: timeline supports |
| D | His wife, Olivia, died of heart failure at the Villa di Quarto near Florence, Italy, on the evening of June 5, 1904, after 22 months of illness; in his notebook that night he wrote that "she that was the life of my life" had died. The anchor for the synthetic prolonged grief disorder a year later. |
confirmed | Fears D. Mark Twain Day by Day: June 5, 1904; July 15, 1909; December 24, 1909 supports Mark Twain: A Life Lived in a Rapidly Changing World (biography) supports Twain in Elmira: timeline supports |
| R | His obituary in The New York Times said that the loss of his son, two daughters and his wife had preyed upon his mind; whether he had a depressive illness at any point cannot be determined from the sources read, and the roster's suggestion of bipolar disorder is not supported by them. Retrospective interpretation; no historical psychiatric diagnosis is assigned. The modern diagnosis of prolonged grief disorder is synthetic. |
possible | Mark Twain Is Dead at 74. The New York Times, April 22, 1910 (transcription) supports HISTMED Master Roster v3 disputes |
| D | He smoked heavily from boyhood: in 1882 he wrote that he had begun to smoke immoderately at eight, starting with one hundred cigars a month and rising to three hundred a month by his thirties, and that cigar smoking did no harm to his health. The anchor for the synthetic tobacco use disorder. |
confirmed | Clemens SL. Letter to A. Arthur Reade, 14 March 1882 (UCCL 02173) supports Mark Twain Is Dead at 74. The New York Times, April 22, 1910 (transcription) supports |
| D | He had his first attack of gout in Paris in about 1894 and was laid up with gout again in Vienna in October 1897. The anchor for the synthetic gout in the modern episode. |
confirmed | Fears D. Mark Twain Day by Day: October 2, 1897 (his letter to Eduard Pötzl) supports |
| D | On May 18, 1905, he arrived for the summer at a rented house at Dublin, New Hampshire, in the hills below Mount Monadnock. Anchors his whereabouts during the modern episode. |
confirmed | Dublin, NH: Summer of 1905 supports |
| D | In August 1905 he was confined to bed with a severe attack of gout while visiting Norfolk, Connecticut. History after the index visit. |
confirmed | Mark Twain Ill of Gout. The New York Times, August 20, 1905 (transcription) supports |
| D | He was confined to his New York home with bronchitis from late April to early May 1906. History after the modern episode. |
confirmed | Mark Twain Out Again. The New York Times, May 7, 1906 (transcription) supports |
| D | In June 1909, in a Baltimore hotel, he had his first attack of chest pain; in July 1909 he wrote that it had been "decided that I have what is technically termed a 'tobacco' heart," that he must smoke four times a day instead of forty, and that the pains came about twice a day. History after the modern episode; anchors nothing in the modern frame except the attention to tobacco and the heart. |
confirmed | Fears D. Mark Twain Day by Day: June 5, 1904; July 15, 1909; December 24, 1909 supports Mark Twain Is Dead at 74. The New York Times, April 22, 1910 (transcription) supports |
| D | His youngest daughter, Jean, who had epilepsy, drowned in her bath at Stormfield on December 24, 1909, during an apparent seizure. History after the modern episode, recorded once without detail. |
confirmed | Fears D. Mark Twain Day by Day: June 5, 1904; July 15, 1909; December 24, 1909 supports Mark Twain: A Life Lived in a Rapidly Changing World (biography) supports |
| D | He died at Stormfield, his house in Redding, Connecticut, on April 21, 1910, at 74, of angina pectoris; his doctors had cut his twenty cigars a day to four, and his physician said he could not show that the angina followed from tobacco. History only, recorded in one plain sentence. |
confirmed | Associated Press report of Mark Twain's death, April 22, 1910 supports Mark Twain Is Dead at 74. The New York Times, April 22, 1910 (transcription) supports Mark Twain: A Life Lived in a Rapidly Changing World (biography) supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Persistent yearning for his wife, broken sleep, low mood and withdrawal from friends and work, a year after her death; cause under evaluation | resolved | confirmed | active | CLM-0007 |
| S | Prolonged grief disorder (DSM-5-TR): more than 12 months after his wife's death, daily yearning and preoccupation with her, with intense emotional pain, a sense that part of himself has died, avoidance of reminders, loneliness, difficulty taking up his work and life again, and a feeling that life is meaningless; PG-13-R 41; major depression not present | active | confirmed | both_with_link | CLM-0004, CLM-0006, CLM-0007 |
| S | Tobacco use disorder, cigars: about fifteen cigars a day, smoking since boyhood, some smoke inhaled; first cigar within thirty minutes of waking | active | confirmed | active | CLM-0009 |
| S | Chest tightness on climbing steep hills, twice in the past month, easing within five minutes of rest; none at rest; cause under evaluation | resolved | confirmed | active | |
| S | Coronary artery disease, nonobstructive (CAD-RADS 2: 25 to 49 percent narrowing of the proximal left anterior descending artery; coronary calcium score 410), with exertional chest tightness that has not recurred on treatment; treated with a statin, aspirin and stopping smoking | active | confirmed | active | |
| S | Gout, recurrent flares of the big toe since his late fifties, two in the past year; serum urate 8.6 mg/dL; no tophi | active | confirmed | active | CLM-0010 |
| S | Acute bronchitis, likely viral, for six days in a cigar smoker; no pneumonia on examination; resolved within three weeks without antibiotics | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 2026-06-12 | Leukocytes [#/volume] in Blood by Automated count | 8.1 10*3/uL Reference 4-11 10*3/uL |
http://loinc.org · 6690-2 |
| S | 2026-06-12 | Hemoglobin [Mass/volume] in Blood | 15.6 g/dL Reference 13.5-17.5 g/dL |
http://loinc.org · 718-7 |
| S | 2026-06-12 | Platelets [#/volume] in Blood by Automated count | 232 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-06-12 | Sodium [Moles/volume] in Serum or Plasma | 140 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-06-12 | Potassium [Moles/volume] in Serum or Plasma | 4.4 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-06-12 | Creatinine [Mass/volume] in Serum or Plasma | 1.08 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-06-12 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 74 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-06-12 | Glucose [Mass/volume] in Serum or Plasma | 101 mg/dL (high) Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-06-12 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 U/L Reference 7-56 U/L |
http://loinc.org · 1742-6 |
| S | 2026-06-12 | Urate [Mass/volume] in Serum or Plasma | 8.6 mg/dL (high) Reference 3.5-7.2 mg/dL |
http://loinc.org · 3084-1 |
| S | 2026-06-12 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.8% (high) Reference <=5.6% |
http://loinc.org · 4548-4 |
| S | 2026-06-12 | Cholesterol [Mass/volume] in Serum or Plasma | 228 mg/dL (high) Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 2026-06-12 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 mg/dL Reference >=40 mg/dL |
http://loinc.org · 2085-9 |
| S | 2026-06-12 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 150 mg/dL (high) Reference <=99 mg/dL |
http://loinc.org · 13457-7 |
| S | 2026-06-12 | Triglyceride [Mass/volume] in Serum or Plasma | 170 mg/dL (high) Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 2026-06-12 | Thyrotropin [Units/volume] in Serum or Plasma | 2.2 mIU/L Reference 0.4-4.5 mIU/L |
http://loinc.org · 3016-3 |
| S | 2026-06-12 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 410 pg/mL Reference 200-900 pg/mL |
http://loinc.org · 2132-9 |
| S | 2026-06-12 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 11 | http://loinc.org · 44261-6 |
| S | 2026-06-12 | Total score [AUDIT-C] | 3 | http://loinc.org · 75626-2 |
| S | 2026-07-17 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | http://loinc.org · 44261-6 |
| S | 2026-09-11 | Cholesterol [Mass/volume] in Serum or Plasma | 156 mg/dL Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 2026-09-11 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 46 mg/dL Reference >=40 mg/dL |
http://loinc.org · 2085-9 |
| S | 2026-09-11 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 74 mg/dL Reference <=99 mg/dL |
http://loinc.org · 13457-7 |
| S | 2026-09-11 | Triglyceride [Mass/volume] in Serum or Plasma | 180 mg/dL (high) Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 2026-09-11 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 28 U/L Reference 7-56 U/L |
http://loinc.org · 1742-6 |
| S | 2026-09-11 | Urate [Mass/volume] in Serum or Plasma | 7.4 mg/dL (high) Reference 3.5-7.2 mg/dL |
http://loinc.org · 3084-1 |
| S | 2026-09-11 | Sodium [Moles/volume] in Serum or Plasma | 139 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-09-11 | Potassium [Moles/volume] in Serum or Plasma | 4.5 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-09-11 | Creatinine [Mass/volume] in Serum or Plasma | 1.1 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-09-11 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 73 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-09-11 | Glucose [Mass/volume] in Serum or Plasma | 98 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-09-11 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | http://loinc.org · 44261-6 |
| S | 2026-10-16 | Urate [Mass/volume] in Serum or Plasma | 6.4 mg/dL Reference 3.5-7.2 mg/dL |
http://loinc.org · 3084-1 |
| S | 2026-10-16 | Sodium [Moles/volume] in Serum or Plasma | 140 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-10-16 | Potassium [Moles/volume] in Serum or Plasma | 4.4 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-10-16 | Creatinine [Mass/volume] in Serum or Plasma | 1.09 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-10-16 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 73 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-10-16 | Glucose [Mass/volume] in Serum or Plasma | 96 mg/dL Reference 70-99 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-10-16 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | http://loinc.org · 44261-6 |
| S | 2026-09-25 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | http://loinc.org · 55758-7 |
| S | 2026-09-25 | Total score [Mini-Cog] | 5 | http://loinc.org · 72233-0 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 2026-06-12 | Body height | 173 cm | 8302-2 | S |
| 2026-06-12 | Body weight | 64 kg | 29463-7 | S |
| 2026-06-12 | Body mass index (BMI) [Ratio] | 21.4 kg/m2 | 39156-5 | S |
| 2026-06-12 | Systolic blood pressure | 142 mm[Hg] | 8480-6 | S |
| 2026-06-12 | Diastolic blood pressure | 84 mm[Hg] | 8462-4 | S |
| 2026-06-12 | Heart rate | 82 /min | 8867-4 | S |
| 2026-06-12 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-06-12 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-06-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 % | 59408-5 | S |
| 2026-06-19 | Body height | 173 cm | 8302-2 | S |
| 2026-06-19 | Body weight | 63.8 kg | 29463-7 | S |
| 2026-06-19 | Body mass index (BMI) [Ratio] | 21.3 kg/m2 | 39156-5 | S |
| 2026-06-19 | Systolic blood pressure | 138 mm[Hg] | 8480-6 | S |
| 2026-06-19 | Diastolic blood pressure | 82 mm[Hg] | 8462-4 | S |
| 2026-06-19 | Heart rate | 80 /min | 8867-4 | S |
| 2026-06-19 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-06-19 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-06-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 % | 59408-5 | S |
| 2026-07-17 | Body height | 173 cm | 8302-2 | S |
| 2026-07-17 | Body weight | 64.1 kg | 29463-7 | S |
| 2026-07-17 | Body mass index (BMI) [Ratio] | 21.4 kg/m2 | 39156-5 | S |
| 2026-07-17 | Systolic blood pressure | 136 mm[Hg] | 8480-6 | S |
| 2026-07-17 | Diastolic blood pressure | 80 mm[Hg] | 8462-4 | S |
| 2026-07-17 | Heart rate | 78 /min | 8867-4 | S |
| 2026-07-17 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-07-17 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-07-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 % | 59408-5 | S |
| 2026-09-11 | Body height | 173 cm | 8302-2 | S |
| 2026-09-11 | Body weight | 64.9 kg | 29463-7 | S |
| 2026-09-11 | Body mass index (BMI) [Ratio] | 21.7 kg/m2 | 39156-5 | S |
| 2026-09-11 | Systolic blood pressure | 130 mm[Hg] | 8480-6 | S |
| 2026-09-11 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-09-11 | Heart rate | 72 /min | 8867-4 | S |
| 2026-09-11 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-09-11 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-09-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 2026-10-16 | Body height | 173 cm | 8302-2 | S |
| 2026-10-16 | Body weight | 65.4 kg | 29463-7 | S |
| 2026-10-16 | Body mass index (BMI) [Ratio] | 21.9 kg/m2 | 39156-5 | S |
| 2026-10-16 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 2026-10-16 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-10-16 | Heart rate | 70 /min | 8867-4 | S |
| 2026-10-16 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-10-16 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-10-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 2026-09-25 | Body height | 173 cm | 8302-2 | S |
| 2026-09-25 | Body weight | 65.1 kg | 29463-7 | S |
| 2026-09-25 | Body mass index (BMI) [Ratio] | 21.8 kg/m2 | 39156-5 | S |
| 2026-09-25 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 2026-09-25 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-09-25 | Heart rate | 70 /min | 8867-4 | S |
| 2026-09-25 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-09-25 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-09-25 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 % | 59408-5 | S |
| 2026-07-31 | Body height | 173 cm | 8302-2 | S |
| 2026-07-31 | Body weight | 63.9 kg | 29463-7 | S |
| 2026-07-31 | Body mass index (BMI) [Ratio] | 21.4 kg/m2 | 39156-5 | S |
| 2026-07-31 | Systolic blood pressure | 134 mm[Hg] | 8480-6 | S |
| 2026-07-31 | Diastolic blood pressure | 80 mm[Hg] | 8462-4 | S |
| 2026-07-31 | Heart rate | 86 /min | 8867-4 | S |
| 2026-07-31 | Respiratory rate | 18 /min | 9279-1 | S |
| 2026-07-31 | Body temperature | 37.5 Cel | 8310-5 | S |
| 2026-07-31 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Writer, humorist and lecturer for more than forty years; known by his pen name; writing most mornings but unable to finish anything since his wife died
- S Widowed a year ago after 34 years of marriage; has lost a son in early childhood and a daughter as a young woman; lives in a rented house in the hills for the summer with a family member, a secretary and household staff; no relative is named or given a role in this record
- S Tobacco: cigars since boyhood, now about fifteen a day and a pipe in the evening, with some smoke inhaled; has stopped for months at a time before and always started again; says cigars help him write
- S Alcohol: a glass of whisky most evenings (AUDIT-C 3); no other drugs
- S Finances: lost everything in a business failure about ten years ago and repaid his creditors by lecturing; secure now; still anxious about money at night
- S No firearms in the house; walks the hill roads most days
- S Strengths: humor, a lifetime of writing, many friends and admirers, neighbors in the summer colony who visit, a daily routine of work, and his own decision to come in
Functional status
- S Independent in all activities and instrumental activities; has stopped seeing friends and turned down every invitation since the winter
Mental status
- S Alert and oriented; courteous, dryly funny even while tearful; speech normal; mood "hollow"; talks of his wife in the present tense and keeps her room as it was; yearning and preoccupation every day; some days wishes he could join her, without any intent or plan; no hallucinations apart from sometimes hearing her voice as he falls asleep, which he knows is not real; thinking clear
Structured safety assessment
This assessment is synthetic and does not convert historical behavior into a present-day fact.
Allergies and medications
Allergies
- S No known allergy
Medications
- S Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four days
- S Varenicline 1 mg oral tablet, one tablet twice daily with food for twelve weeks, with a quit date in the second week
- S Atorvastatin 40 mg oral tablet, one tablet daily
- S Aspirin 81 mg delayed-release oral tablet, one tablet daily
- S Allopurinol 100 mg oral tablet, one tablet daily
- S Allopurinol 100 mg oral tablet, two tablets daily (200 mg)
- S Allopurinol 300 mg oral tablet, one tablet daily
- S Colchicine 0.6 mg oral tablet, one tablet daily for flare prevention while allopurinol is started, for three to six months
- S Prednisone 20 mg oral tablet, two tablets (40 mg) each morning for five days, for a gout flare, prescribed by a doctor where he was staying
Procedures and immunizations
Procedures
- S Resting 12-lead electrocardiogram: sinus rhythm at 80 per minute, normal axis and intervals, no Q waves or ST-segment changes
- S CT coronary angiography with calcium scoring: coronary calcium score 410; 25 to 49 percent narrowing of the proximal left anterior descending artery from mixed plaque (CAD-RADS 2); no obstructive disease
- S Advance care planning conversation, about 20 minutes
Immunizations
- S 2026-09-25: High-dose influenza vaccine for the coming season
- S 2026-09-25: Pneumococcal conjugate vaccine (PCV20); no earlier pneumococcal vaccine
- S 2026-10-16: RSV vaccine, single dose, for an adult aged 60 to 74 with coronary disease
- S 2026-10-16: Recombinant zoster vaccine, first of two doses
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D June 1872: Death of his son at about two, from diphtheria (CLM-0004)
- D 1894 to 1896: Bankruptcy after the failure of his publishing company, followed by a worldwide lecture tour to repay his debts (CLM-0005)
- D about 1894 and 1897: Gout: a first attack in Paris and a further attack in Vienna three years later (CLM-0010)
- D August 1896: Death of his eldest daughter at 24, from meningitis (CLM-0006)
- D June 5, 1904: Death of his wife after 22 months of illness, a year before the index visit (CLM-0007)
Family history
No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| PG-13-R below 30 and back to writing and seeing friends | 2026-10-16 | completed | PG-13-R 41 at intake to 26 at eighteen weeks; finishing a long essay; dinner with friends weekly |
| No thoughts of death and a safety plan he would use | 2026-09-11 | completed | Passive thoughts of death at intake; none since the five-week visit; safety plan kept |
| Stop smoking cigars | 2026-10-16 | active | Fifteen cigars a day at intake; quit in the first week of August with varenicline; one lapse of two cigars while away; none for eight weeks |
| LDL cholesterol at least 50 percent lower on a high-intensity statin | 2026-09-11 | completed | LDL 150 to 74 mg/dL (51 percent lower) at eight weeks |
| Serum urate below 6 mg/dL and no gout flares | 2026-10-16 | active | Urate 8.6, 7.4 and 6.4 mg/dL; one flare in August, treated while away; allopurinol raised to 300 mg |
| Six or more hours of sleep on most nights without a sleeping pill | 2026-10-16 | completed | About four to five hours at intake; six hours on most nights by eighteen weeks |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Geriatric psychiatry consultation to confirm the diagnosis, separate prolonged grief disorder from major depression, advise on grief therapy, medicine and sleep, and review suicide risk | completed | GL-APA-PGD, GL-PG13R-2021, GL-SUICIDE-2024 |
| Safety: a structured safety assessment, a written safety plan, the 988 Suicide & Crisis Lifeline in his phone, means safety, a telephone call in three days, and safety review at every visit | completed | GL-SUICIDE-2024, GL-BEREAVED-MEN-2004, GL-CMID-2026 |
| Prolonged grief disorder therapy (Shear): sixteen weekly sessions with a trained psychologist, covering the story of the death, imaginal conversations with his wife, memories and pictures, revisiting avoided places and things, and personal goals; PG-13-R and PHQ-9 every four weeks; no antidepressant unless major depression develops | completed | GL-PGDT-2005, GL-PGDT-2016, GL-APA-PGD, GL-PG13R-2021 |
| Sleep: a fixed rising time, no naps after noon, no cigar or whisky in the last hours before bed, and getting up if awake more than twenty minutes; no benzodiazepine, zolpidem or sedating antihistamine | completed | GL-PGDT-2016, GL-CMID-2026 |
| Tobacco: his readiness asked at every visit; brief advice linked to his own concern about his heart; counseling at each visit and the state quitline; varenicline offered as the most effective single medicine, with combination nicotine replacement as the alternative | completed | GL-USPSTF-TOB-2021 |
| Chest tightness on exertion: resting ECG today and CT coronary angiography, chosen over stress testing for a man over 65 with stable symptoms and no known coronary disease; call 911 for chest pain at rest or lasting more than fifteen minutes | completed | GL-CHESTPAIN-2021 |
| Nonobstructive coronary disease: atorvastatin 40 mg with a lipid panel 4 to 12 weeks later and a goal of at least a 50 percent fall in LDL, aspirin 81 mg, blood pressure below 130/80 mmHg, stopping smoking, and walking most days | completed | GL-CCD-2023, GL-CMID-2026 |
| Gout: allopurinol from 100 mg daily, raised by 100 mg every two to five weeks to a serum urate below 6 mg/dL, with colchicine 0.6 mg daily for three to six months to prevent flares; flares treated without stopping allopurinol; HLA-B*58:01 testing not indicated by ancestry; less alcohol | completed | GL-ACR-GOUT-2020 |
| Social connection and his writing: one planned social contact a week, a return to morning writing on a set project, and the clinic social worker's list of local groups; meaning and goals to be part of any grief treatment | completed | GL-PGDT-2005 |
| Gout: urate measured at intake; urate-lowering therapy explained, since two flares in a year make it strongly recommended; he chose to decide after the chest evaluation; call at the first sign of a flare | completed | GL-ACR-GOUT-2020 |
| Cardiovascular risk: blood pressure at each visit and lipids, hemoglobin A1c and kidney function at baseline; prediabetes (hemoglobin A1c 5.8 percent) managed with walking and diet | completed | GL-CMID-2026, GL-CHESTPAIN-2021 |
Planned encounters
- 2026-06-12 — Establishing primary care a year after his wife's death: yearning, poor sleep, low mood and withdrawal, suicide risk, heavy cigar smoking, chest tightness on hills, gout and cardiovascular risk (ENC-001)
- 2026-06-19 — One-week review, seen the same day by geriatric psychiatry: the diagnosis of prolonged grief disorder, grief therapy, sleep and safety (ENC-002)
- 2026-07-17 — Five-week review: CT coronary angiography result, a statin and aspirin, a plan to quit smoking, and starting allopurinol (ENC-003)
- 2026-07-31 — Same-day sick visit for a cough (ENC-007, unscheduled)
- 2026-09-11 — Thirteen-week review: grief therapy, smoking, a gout flare while away, the urate and lipid results (ENC-004)
- 2026-09-25 — Subsequent annual wellness visit (ENC-006)
- 2026-10-16 — Eighteen-week review: grief, no smoking, urate toward target and his writing (ENC-005)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Sick Visit
- Progress note 05 — Focused Visit (Follow-up)
- Progress note 06 — Annual Wellness Visit, Subsequent
- Progress note 07 — Focused Visit (Care-plan review)
- Geriatric Psychiatry referral
- Geriatric Psychiatry consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Sick Visit (XML)
- Progress note 05 — Focused Visit (Follow-up) (XML)
- Progress note 06 — Annual Wellness Visit, Subsequent (XML)
- Progress note 07 — Focused Visit (Care-plan review) (XML)
- Geriatric Psychiatry referral (XML)
- Geriatric Psychiatry consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Mark Twain: A Life Lived in a Rapidly Changing World (biography) | The Mark Twain House & Museum | biography |
| SRC-0002 | Twain in Elmira: timeline | Center for Mark Twain Studies, Elmira College | biography |
| SRC-0003 | Clemens SL. Letter to A. Arthur Reade, 14 March 1882 (UCCL 02173) | Mark Twain Project Online, University of California, Berkeley | primary |
| SRC-0004 | Mark Twain Is Dead at 74. The New York Times, April 22, 1910 (transcription) | TwainQuotes.com (transcription of The New York Times) | primary |
| SRC-0005 | Fears D. Mark Twain Day by Day: June 5, 1904; July 15, 1909; December 24, 1909 | Twain's Geography (digital edition of Mark Twain Day by Day, via the Center for Mark Twain Studies) | biography |
| SRC-0006 | Fears D. Mark Twain Day by Day: October 2, 1897 (his letter to Eduard Pötzl) | Twain's Geography (digital edition of Mark Twain Day by Day) | biography |
| SRC-0007 | Dublin, NH: Summer of 1905 | Twain's Geography (digital edition of Mark Twain Day by Day) | biography |
| SRC-0008 | Mark Twain Ill of Gout. The New York Times, August 20, 1905 (transcription) | TwainQuotes.com (transcription of The New York Times) | primary |
| SRC-0009 | Mark Twain Out Again. The New York Times, May 7, 1906 (transcription) | TwainQuotes.com (transcription of The New York Times) | primary |
| SRC-0010 | HISTMED Master Roster v3 | The Human Record project | other |
| SRC-0011 | Associated Press report of Mark Twain's death, April 22, 1910 | Mark Twain in His Times, University of Virginia Library | primary |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the DSM-5-TR prolonged grief disorder diagnosis and the decision that major depression is absent and no antidepressant is needed, the outpatient safety plan for passive thoughts of death in an older bereaved man, prolonged grief disorder therapy, varenicline for a cigar smoker with coronary disease, CT coronary angiography for exertional chest tightness, the statin and aspirin for nonobstructive disease, and allopurinol titration with colchicine prophylaxis and a prednisone-treated flare. |
| provenance review | not_started | Sources: the Mark Twain House & Museum biography, the Center for Mark Twain Studies timeline, a Mark Twain Project letter (1882), Mark Twain Day by Day (Twain's Geography), transcriptions of The New York Times (1905, 1906 and the 1910 obituary) and the University of Virginia's copy of the 1910 Associated Press report. The Library of Congress pages, the autobiography and any peer-reviewed article on his health were not read. The roster's bipolar lead is not used. |
| safe messaging review | not_started | Bereavement and mental health claims are marked sensitive and recorded plainly; his daughter's death is recorded once without detail; no psychiatric diagnosis is assigned to the historical person; the safety assessment gives the 988 Suicide & Crisis Lifeline and addresses means safety. His family members are documented history only; nothing in the modern episode is attributed to them. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.